Tuesday 25 August 2015

FDA draft guidance on injectable volume excess

The U.S. Food and Drug Administration (FDA) has issued a new draft guidance document. This guidance clarifies FDA requirements and regulations pertaining to allowable excess volume in injectable vials and reinforces the importance of appropriate fill volumes and labeled vial fill sizes for injectable drug and biological products.

The guidance can be accessed here: FDA

Posted by Tim Sandle

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers